a new association between the 4 - (cis) hexahydrocyclopenta (c) pyrrol (1) (h)) - yl) propoxy) benzamide and n-methyl-d-aspartate (nmda) receptors antagonist, pharmaceutical compositions containing and.
association between the 4 - (3 - (cis - pyrrol hexahydrocyclopenta (c) - 2 (1h) - yl) propoxy) benzamide of formula (1) or one of its salts or acid addition in a pharmaceutically acceptable base was an antagonist of nmda receptors and glutamate.ASSOCIATION ENTRE LE 4-(3-(CIS-HEXAHYDROCYCLOPENTA(C)PYRROL-2(1H)-YL)PROPOXY)BENZAMIDE DE FORMULE(1)OU UN DE SES SELS D'ADDITION A UN ACIDE OU A UNE BASE PHARMACEUTIQUEMENT ACCEPTABLE ET UN ANTAGONISTE DES RECEPTEURS GLUTAMATERGIQUES NMDA.